Compare ARCO & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCO | FTRE |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | Uruguay | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2011 | N/A |
| Metric | ARCO | FTRE |
|---|---|---|
| Price | $7.37 | $17.40 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 8 |
| Target Price | $8.60 | ★ $12.64 |
| AVG Volume (30 Days) | 900.9K | ★ 1.4M |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.27% | N/A |
| EPS Growth | ★ 69.06 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $4,555,936,000.00 | $2,759,900,000.00 |
| Revenue This Year | $6.35 | $3.17 |
| Revenue Next Year | $7.64 | $0.11 |
| P/E Ratio | $6.29 | ★ N/A |
| Revenue Growth | 1.21 | ★ 1.88 |
| 52 Week Low | $6.51 | $3.97 |
| 52 Week High | $8.52 | $20.26 |
| Indicator | ARCO | FTRE |
|---|---|---|
| Relative Strength Index (RSI) | 52.36 | 73.61 |
| Support Level | $7.09 | $17.11 |
| Resistance Level | $7.40 | $18.29 |
| Average True Range (ATR) | 0.14 | 0.94 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 57.45 | 80.68 |
Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.